Geoffrey Martha - 28 Jul 2025 Form 4 Insider Report for Medtronic plc (MDT)

Signature
/s/ Patricia Walesiewicz, attorney-in-fact
Issuer symbol
MDT
Transactions as of
28 Jul 2025
Transactions value $
$0
Form type
4
Filing time
30 Jul 2025, 16:24:48 UTC
Previous filing
14 Feb 2025
Next filing
04 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Martha Geoffrey Chairman and CEO, Director 710 MEDTRONIC PARKWAY, MINNEAPOLIS /s/ Patricia Walesiewicz, attorney-in-fact 30 Jul 2025 0001560409

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Award $0 +37.5K +19.9% $0.00 226K 28 Jul 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Units Award $0 +93.8K $0.00 93.8K 28 Jul 2025 Performance Share Unit 93.8K Direct F3, F4, F5
transaction MDT Stock Option (Right to Buy) Award $0 +265K $0.00 265K 28 Jul 2025 Ordinary Shares 265K $91.97 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
F2 Includes 1,693 shares acquired through dividend reinvestment since the last report filed by the reporting person.
F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F4 Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028.
F5 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 93,781 shares will be issued. If maximum performance metrics are achieved, 187,562 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F6 These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.